Detalles de la búsqueda
1.
A mouse-adapted SARS-CoV-2 strain replicating in standard laboratory mice.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-451880
2.
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without Omicron breakthrough infection.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277885
3.
The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436013
4.
A measles-vectored COVID-19 vaccine induces long-term immunity and protection from SARS-CoV-2 challenge in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-431630
5.
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-079608
6.
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278699
7.
Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272066
8.
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-516888
9.
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-475248
10.
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-445838
11.
Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-486719
Resultados
1 -
11
de 11
1
Próxima >
>>